Total Payments
$673.39
2024 Payments
$147.61
Companies
13
Transactions
22
Medicare Patients
1,254
Medicare Billing
$115,629
Payment Breakdown by Category
Food & Beverage$673.39 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $673.39 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $166.91 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $91.10 | 3 | $0 (2023) |
| Merz Pharmaceuticals, LLC | $80.61 | 2 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $64.53 | 3 | $0 (2023) |
| GE HealthCare | $52.26 | 2 | $0 (2023) |
| Kyowa Kirin, Inc. | $50.66 | 3 | $0 (2024) |
| Dompe US, Inc. | $33.12 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $31.51 | 1 | $0 (2024) |
| ABBVIE INC. | $22.34 | 1 | $0 (2024) |
| Novocure Inc. | $21.23 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.61 | 6 | Alexion Pharmaceuticals, Inc. ($33.78) |
| 2023 | $383.52 | 11 | Alexion Pharmaceuticals, Inc. ($133.13) |
| 2022 | $142.26 | 5 | Horizon Therapeutics plc ($69.92) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/10/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: Rare Disease | ||||||
| 03/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Neurology | ||||||
| 08/10/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| 08/08/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Oncology | ||||||
| 06/13/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Neurology | ||||||
| 05/26/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $26.13 | General |
| 05/26/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $26.13 | General |
| 05/24/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: Musculoskeletal | ||||||
| 02/22/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $133.13 | General |
| Category: Rare Disease | ||||||
| 02/09/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $50.04 | General |
| Category: Musculoskeletal | ||||||
| 02/08/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: TEPEZZA | ||||||
| 01/19/2023 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Adenosine A2A Receptors | ||||||
| 12/08/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: TEPEZZA | ||||||
| 11/15/2022 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/25/2022 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Neurology | ||||||
| 10/20/2022 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/14/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $49.73 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,057 | 1,399 | $581,366 | $98,768 |
| 2022 | 6 | 197 | 224 | $95,828 | $16,861 |
Total Patients
1,254
Total Services
1,623
Medicare Billing
$115,629
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 200 | 200 | $160,200 | $27,288 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 161 | $99,659 | $16,448 | 16.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 194 | 276 | $87,216 | $15,418 | 17.7% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 185 | 265 | $83,740 | $13,947 | 16.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 176 | 276 | $50,232 | $8,280 | 16.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $27,430 | $4,961 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 30 | $25,920 | $4,530 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 58 | $25,462 | $4,317 | 17.0% |
| 92134 | Imaging of retina | Office | 2023 | 96 | 107 | $21,507 | $3,579 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $45,480 | $8,051 | 17.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 38 | 42 | $13,272 | $2,381 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 21 | $13,062 | $2,343 | 17.9% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 31 | 37 | $11,544 | $2,001 | 17.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 46 | 56 | $10,248 | $1,716 | 16.7% |
| 92134 | Imaging of retina | Office | 2022 | 11 | 11 | $2,222 | $368.66 | 16.6% |
About Dr. Alexander Solomon, M.D
Dr. Alexander Solomon, M.D is a Neuro-ophthalmology healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2017. The National Provider Identifier (NPI) number assigned to this provider is 1306372602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Solomon, M.D has received a total of $673.39 in payments from pharmaceutical and medical device companies, with $147.61 received in 2024. These payments were reported across 22 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($673.39).
As a Medicare-enrolled provider, Solomon has provided services to 1,254 Medicare beneficiaries, totaling 1,623 services with total Medicare billing of $115,629. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuro-ophthalmology
- Location Torrance, CA
- Active Since 05/04/2017
- Last Updated 01/25/2024
- Taxonomy Code 207WX0109X
- Entity Type Individual
- NPI Number 1306372602
Products in Payments
- SOLIRIS (Biological) $133.13
- TEPEZZA (Drug) $91.10
- Xeomin (Biological) $80.61
- Dysport (Drug) $41.27
- Nourianz (Drug) $34.70
- ULTOMIRIS (Biological) $33.78
- OXERVATE (Drug) $33.12
- MEKINIST (Drug) $31.51
- DYSPORT (Drug) $23.26
- BOTOX (Biological) $22.34
- Optune (Device) $21.23
- UPLIZNA (Biological) $20.20
- Vitrakvi (Drug) $19.14
- NOURIANZ (Drug) $15.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.